Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series

Bibliographic Details
Main Authors:	Grace C. Brummer, BS, Jason E. Hawkes, MD, Kristina Callis Duffin, MD, MS
Format:	Article
Language:	English
Published:	Elsevier 2017-09-01
Series:	JAAD Case Reports
Subjects:	guttate psoriasis HLA-C*06:02 psoriasis ustekinumab
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512617301273

Similar Items

Histone Deacetylase 1 and Sirtuin 1 Expression in Psoriatic Skin: A Comparison between Guttate and Plaque Psoriasis
by: Young-Ji Hwang, et al.
Published: (2020-08-01)

SARS‐CoV‐2 and guttate psoriasis: A case report and review of literature
by: Elrazi Ali, et al.
Published: (2021-07-01)

Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab
by: Amy J. Petty, BS, et al.
Published: (2020-08-01)

Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis
by: Maeve Lynch, MD, MBBChBAO, et al.
Published: (2017-05-01)

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
by: Norman Wasel, et al.
Published: (2020-05-01)

Erythema multiforme after initiation of anti interleukin-12/23 (ustekinumab) treatment for plaque psoriasis
by: Martina Burlando, MD, et al.
Published: (2020-05-01)

Ustekinumab successfully treated a patient with severe psoriasis vulgaris with primary failure to infliximab and secondary failure to adalimumab
by: Chiharu Tateishi,, et al.
Published: (2015-07-01)

Changes in metabolic parameters in psoriasis patients treated with interleukin-12/23 blockade (ustekinumab)
by: Chau Yee Ng, et al.
Published: (2020-01-01)

New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette–Guerin
by: Chih-Tsung Hung, et al.
Published: (2012-09-01)

Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Efficiency ustekinumab in the treatment of patients with psoriasis with metabolic disorders
by: I. V. Rychkova, et al.
Published: (2019-08-01)

Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab
by: Jeanette Halskou Hesselvig, et al.
Published: (2017-12-01)

Childhood psoriasis: What is new and what is news
by: Sunil Dogra, et al.
Published: (2018-01-01)

Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
by: Ting-Shun Wang, et al.
Published: (2017-03-01)

Ustekinumab treats psoriasis by suppressing RORC and T-box but its suppression of GATA restrains its efficacy
by: Lun-Fei Liu, et al.
Published: (2019-04-01)

Effectiveness of resuming ustekinumab therapy in psoriasis patients with metabolic disorders. Clinical experience
by: I. V. Rychkova, et al.
Published: (2019-02-01)

Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)
by: Jerry Bagel, et al.
Published: (2018-10-01)

Efficacy and safety of ustekinumab in adolescents
by: Kellen R, et al.
Published: (2016-09-01)

The use of ustekinumab in patients with psoriasis and coexisting renal or hepatic dysfunction – a report of two cases
by: Hubert Arasiewicz, et al.
Published: (2014-10-01)

Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
by: Rosita Saraceno, et al.
Published: (2013-09-01)

Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis
by: Misbah N. Ghazanfar, et al.
Published: (2019-07-01)

Hypophysitis following Treatment with Ustekinumab: Radiological and Pathological Findings
by: Ana M. Ramos-Leví, et al.
Published: (2018-03-01)

Ustekinumab Drug Survival in Patients with Psoriasis: A retrospective Study of Real Clinical Practice
by: Cristina Galache Osuna, et al.
Published: (2020-10-01)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
by: Matsumoto S, et al.
Published: (2018-07-01)

Bulky Condyloma Acuminata following Ustekinumab Treatment for Plaque Psoriasis: A Case Report
by: Martina Burlando, et al.
Published: (2021-04-01)

Late reaction to ustekinumab infusion
by: Marina Resener Morais, et al.
Published: (2013-09-01)

RESULTS OF USTEKINUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS IN THE RUSSIAN FEDERATION ACCORDING TO THE DATA OF PSUMMIT 1 AND PSUMMIT 2
by: Yu. L. Korsakova, et al.
Published: (2015-04-01)

Use of Ustekinumab in the Treatment of Libyan Psoriasis Vulgaris Patients
by: Beltammer Belkais, et al.
Published: (2019-03-01)

The combined using of ustekinumab and narrow-band phototherapy in treatment of severe psoriasis
by: Kruglova L.S., et al.
Published: (2015-09-01)

Ankilozan Spondilit, Crohn Hastalığı ve Anti-tümör Nekroz Faktör-alfa Tedavi ile İndüklenen Psoriasis olan Hastada Ustekinumab Tedavisine Dramatik Yanıt
by: Sevilay Kılıç, et al.
Published: (2020-12-01)

Ustekinumab in patients with Crohn’s disease with extraintestinal manifestations (psoriasis)
by: P. A. Makarchuk, et al.
Published: (2020-10-01)

Association of Streptococcus with Plaque Type of Psoriasis
by: Mohammad Akram Hossain, et al.
Published: (2015-05-01)

Ustekinumab in Real-Life Practice: Experience in 116 Patients with Moderate-To-Severe Psoriasis
by: Inês Raposo, et al.
Published: (2019-03-01)

Ustekinumab-induced fixed drug eruption
by: Dhafer M. Hafez, MD, et al.
Published: (2020-12-01)

Use of ustekinumab after other biological therapies in moderate-severe psoriasis: Real long-term data
by: Manuel David Gil-Sierra, et al.
Published: (2020-09-01)

Generalised pustular psoriasis – a case report and review of therapeutic approaches
by: Agnieszka Osmola-Mańkowska
Published: (2014-11-01)

Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab
by: S. Signa, et al.
Published: (2019-07-01)

Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
by: Nicole L. Bolick, et al.
Published: (2020-12-01)

A case report of heart failure after therapy with ustekinumab
by: Kourosh Beroukhim, et al.
Published: (2015-07-01)

The cost of biologics for psoriasis is increasing
by: Judy Cheng, et al.
Published: (2014-12-01)